Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma, Large B-Cell, Diffuse 3Gliosarcoma 3Glioma 3Glioblastoma 3Dendritic Cell Sarcoma, Interdigitating 3Oligodendroglioma 2Astrocytoma 2Sarcoma, Kaposi 1Recurrence 1Neuroectodermal Tumors, Primitive 1Meningioma 1Lymphoma 1Histiocytosis, Langerhans-Cell 1Histiocytic Sarcoma 1Heart Failure 1HIV Infections 1Erdheim-Chester Disease 1Ependymoma 1Central Nervous System Neoplasms 1Cardiotoxicity 1Brain Neoplasms 1AIDS-related Kaposi sarcoma 1

Interventions

Doxorubicin 11Zidovudine 9Vincristine 8Bleomycin 7Liposomes 5Interferon alpha-2 5tecogalan 4Etoposide 4Specimen Handling 3Magnetic Resonance Spectroscopy 3Biopsy 3sargramostim 2interferon alfa-n1 2Semaxinib 2Rituximab 2Ritonavir 2Polymerase Chain Reaction 2Nivolumab 2Mitoxantrone 2Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 2Didanosine 2Alitretinoin 2vesnarinone 1tin etiopurpurin 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1pembrolizumab 1nirogacestat 1fludarabine phosphate 1emvododstat 1efineptakin alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × Lenalidomide × Sarcoma × Clear all
NCT01057121 2022-02-08

Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma

National Cancer Institute (NCI)

Phase 1/2 Completed
38 enrolled 11 charts
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡